-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Hong Kong RGC approved HK$400 million to fund eight research projects, two involving COVID-19 |
China News Service , Hong Kong, July 13th (Reporter Han Xingtong) The Hong Kong Research Grants Council (RGC) announced on the 13th the funding results of the 2021/2022 thematic research plan.
8 outstanding research proposals have been approved for funding of more than 400 million yuan (Hong Kong dollars, the same below), of which 2 items are related to new coronary pneumonia
.
It is reported that 8 outstanding research proposals have been approved for a total of 415 million yuan, of which 367 million yuan is provided by the RGC and 48 million yuan is provided by the relevant universities in a matching manner
.
It can be seen from the funding document that 2 of the 8 research projects are related to the new crown pneumonia, which are "virological, immunological and epidemiological characteristics of the new crown virus" to reveal the spread and pathogenicity of the virus and formulate a vaccine against the new crown pneumonia The other project is "New Coronavirus Ecology, Molecular Virology and Pathogenic Mechanism: From Clinical to Experimental and Back to Clinical", to propose a new plan to develop a live attenuated vaccine and a synthetic vaccine for the new coronavirus, and Create new drugs against the new coronavirus or host
.
The study involved the university of Hong Kong Chinese University, Hong Kong University, Hong Kong University of Science and Technology and the Hong Kong Baptist University
Hong Kong Hong Kong Hong Kong Hong Kong
The remaining six research projects cover areas such as neonatal liver disease, stem cell engineering, the creation of thermal comfort communities, green finance, early childhood academic achievement, and art and technology
.
Huang Yushan, chairman of theRGC , said that he expects the above-mentioned projects to bring social and economic benefits to Hong Kong
.
He also revealed that in addition to the 230 million yuan funding for regular thematic research projects, the RGC has allocated an additional 100 million yuan for the 2021/2022 thematic research projects to fund research related to new coronary pneumonia and other new infectious diseases
Chairman Hong Kong focuses on the new crown pneumonia epidemic